Skip to main content

Table 3 Factors associated with ITN use, health care-seeking and IPTp-SP in rural Chikwawa

From: Access and adequate utilization of malaria control interventions in rural Malawi: a descriptive quantitative study

 

aOR (95% CI)

ITN use

 Participants

  Children

Ref

  Women

0.84 (0.69–1.00)

 Wealth

  Lowest

Ref

  Second

1.90 (1.36–2.64)

  Middle

1.28 (0.93–1.77)

  Fourth

1.74 (1.26–2.41)

  Top

 

 Sampling round

  April–May’15

Ref

  June–July’15

0.75 (0.57–0.98)

  August–September’15

0.63 (0.48–0.84)

  October–November’15

0.44 (0.32–0.58)

  January–March’16

0.53 (0.40–0.71)

 Household size

0.98 (0.94–1.03)

Sought treatment

 Participants

  Children

Ref

  Women

0.52 (0.34–0.79)

 Wealth

  Lowest

Ref

  Second

0.85 (0.41–1.76)

  Middle

0.87 (0.43–1.75)

  Fourth

1.29 (0.64–2.61)

  Top

1.67 (0.84–3.32)

 Sampling round

  April–May’15

Ref

  June–July’15

1.01 (0.60–1.70)

  August–September’15

0.87 (0.47–1.62)

  October–November’15

0.76 (0.35–1.64)

  January–March’16

0.80 (0.37–1.73)

 Distance to health facility (km)

1.06 (0.95–1.19)

 Total people in household

1.04 (0.92–1.17)

3 or more IPTp-SP doses

 Age

0.997 (0.99–1.00)

 Education category

  None

Ref

  Some primary

0.54 (0.28–1.02)

  Completed primary or some secondary

0.90 (0.34–2.40)

  Completed secondary

0.47 (0.05–4.63)

 Wealth quintile

  Lowest

Ref.

  Second

1.75 (0.70–4.41)

  Middle

1.26 (0.50–3.17)

  Fourth

1.58 (0.64–3.90)

  Top

1.47 (0.53–4.09)

 Distance to health facility (km)

0.93 (0.79–1.09)

  1. Italic confidence intervals are statistically significant
  2. aOR adjusted odds ratio, CI confidence interval, IPTp-SP intermittent preventive treatment in pregnancy with sulfadoxine pyrimethamine